AHA Coding Clinic® for HCPCS - 2018 Issue 2; Ask the Editor
Stravix
Patient with a chronic pressure ulcer of the right lateral malleolus presents for excision of the ulcer. The excision (6x5 cm) was taken down to the fascia and necrotic tissue was removed. A 4x7 cm piece of StravixTM was placed and sutured into the wound and Prolene was used to close over the Stravix™. The dermis was closed and a splint was placed on the foot to prevent movement. Would this be coded using skin substitute graft CPT codes 15275 and 15276 or placement of soft tissue reinforcement CPT code 17999? Is there a HCPCS code for the Stravix™ utilized? ...
Subscribe or sign in to view the full article.
Article Overview
This article addresses a procedure scenario involving excision of a chronic pressure ulcer, placement of a biologic wound product, and subsequent closure. It is aimed at coding professionals seeking guidance on how the service may be reported, including whether the service aligns with skin substitute graft reporting, an unlisted soft tissue reinforcement code, and whether a HCPCS identifier exists for the product. The article also includes a coding assignment note tied to debridement of muscle and/or fascia.
Why This Topic Matters
Accurate reporting of wound procedures and graft-related services affects claim submission, coding consistency, and payer review. This topic is relevant to coders, billers, and clinicians involved in surgical wound management and product-based procedures.
What You Will Learn
- How the article frames coding questions around a wound procedure with a biologic product
- What broad CPT and HCPCS reporting areas are being considered
- How the scenario connects wound excision, closure, and product placement to coding review
- Why debridement coding is mentioned in relation to the case
Who Should Read This
- Medical coders
- Billing staff
- Surgical coders
- Wound care specialists
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com